Skip to content

Bioventus BVS Shares (Diluted)

Shares (Diluted) at other companies

Stryker logo
StrykerSYK
386.5M0.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
40.5M+3.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
195.8M-2.0%
Medtronic logo
MedtronicMDT
1.3B-0.1%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
44M+3.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
224.1M+32.3%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's shares (diluted)?
Bioventus (BVS) reported shares (diluted) of 70M in Q1 2026.
How has Bioventus's shares (diluted) changed year-over-year?
Bioventus's shares (diluted) increased by 6.1% year-over-year, from 66M to 70M.
What is the long-term trend for Bioventus's shares (diluted)?
Over 4 years (2021 to 2025), Bioventus's shares (diluted) has grown at a 12.3% compound annual growth rate (CAGR), from 170.9M to 272.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.